ANA Gold (Gold Tripeptide-1)
ANA Gold is a colloidal gold-tripeptide-1 conjugate that combines gold nanoparticle anti-inflammatory and antioxidant properties with tripeptide-1's collagen-stimulating activity for luxury anti-aging skincare applications.
ANA Gold (also marketed as Anakin Gold or Gold Tripeptide-1) is a gold nanoparticle-peptide conjugate that combines colloidal gold with tripeptide-1 (GHK, glycyl-histidyl-lysine) to create a dual-action anti-aging ingredient. The gold nanoparticles provide anti-inflammatory, antioxidant, and light-reflecting properties, while the tripeptide-1 component stimulates collagen synthesis, promotes wound healing, and modulates gene expression.
Overview
Gold has been used in medicine and skincare for millennia, from ancient Egyptian and Ayurvedic traditions to modern rheumatology (gold salts for rheumatoid arthritis). The development of colloidal gold nanoparticle technology enabled precise control over particle size, surface chemistry, and biological interactions. ANA Gold leverages this technology by conjugating gold nanoparticles (typically 10-50 nm diameter) with tripeptide-1, creating a stable complex that combines the properties of both components.
Tripeptide-1 (GHK) is the same peptide backbone found in GHK-Cu, but in ANA Gold the peptide is conjugated to gold rather than copper. The gold-peptide interaction occurs through coordination with the histidine imidazole group and the amine terminus, similar to copper coordination but with different electronic and biological consequences. Gold nanoparticles do not participate in redox cycling the way copper does, instead providing anti-inflammatory effects through inhibition of NFkB and AP-1 transcription factors and antioxidant effects through catalytic scavenging of reactive oxygen species.
Mechanism of Action
ANA Gold exerts its effects through two complementary pathways -- the gold nanoparticle component and the tripeptide-1 component:
Gold Nanoparticle Activity
- Anti-inflammatory signaling: Gold nanoparticles inhibit NFkB and AP-1 transcription factor activation, reducing production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) in dermal cells
- Antioxidant catalysis: Gold nanoparticles exhibit intrinsic catalase-like and superoxide dismutase-like activity, scavenging reactive oxygen species (ROS) without being consumed in the reaction
- Collagen protection: By reducing MMP (matrix metalloproteinase) expression through NFkB inhibition, gold nanoparticles protect existing collagen from enzymatic degradation
- Light interaction: Gold nanoparticles exhibit surface plasmon resonance, producing characteristic light scattering that contributes to immediate skin radiance effects
Tripeptide-1 Activity
- Collagen stimulation: GHK activates fibroblast collagen synthesis through matrikine signaling pathways
- Gene expression modulation: The tripeptide alters expression of genes involved in tissue repair, antioxidant response, and inflammation Pickart et al. (2014)
- Wound healing: GHK promotes fibroblast migration, angiogenesis, and extracellular matrix remodeling
- Metal chelation: The peptide can chelate trace metals from the skin environment, potentially reducing metal-catalyzed oxidative damage
Synergistic Effects
The gold-peptide conjugate produces effects that exceed the sum of individual components. Gold nanoparticles enhance peptide stability by protecting against proteolytic degradation, while the peptide coating improves gold nanoparticle biocompatibility and cellular uptake. The anti-inflammatory effects of gold complement the regenerative signaling of the tripeptide, creating a dual "protect and repair" mechanism.
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Collagen Stimulation Studies
The tripeptide-1 component of ANA Gold shares its collagen-stimulating mechanism with GHK-Cu. Studies on GHK peptides demonstrate increased collagen I, collagen III, and elastin synthesis in human dermal fibroblasts. The gold conjugate may offer improved stability compared to the copper complex, as gold does not participate in Fenton chemistry and does not generate hydroxyl radicals under physiological conditions.
Luxury Skincare Applications
ANA Gold is primarily positioned in the premium skincare segment, where it is formulated into serums, masks, and concentrated treatments. Clinical evaluations by manufacturers report improvements in skin firmness (up to 40% after 8 weeks), radiance (visible improvement within 2 weeks), and fine line depth (20-30% reduction after 12 weeks of daily application). These results should be interpreted in the context of manufacturer-sponsored studies.
Wound Healing Potential
The combination of gold's anti-inflammatory activity with tripeptide-1's tissue repair signaling creates a theoretical synergy for wound healing applications. Preclinical research on gold nanoparticle-peptide systems has shown accelerated wound closure, reduced inflammatory cell infiltration, and improved collagen deposition at wound sites.
Gold Nanoparticles in Dermatology
Gold nanoparticles have been extensively studied for biomedical applications including drug delivery, photothermal therapy, and diagnostics. In dermatology, research has focused on their anti-inflammatory and antioxidant properties:
- Mukherjee et al. (2007) demonstrated that gold nanoparticles inhibit VEGF-165-induced proliferation of endothelial cells, suggesting anti-angiogenic properties relevant to inflammatory skin conditions
- Gold nanoparticles reduce UV-induced oxidative stress in keratinocytes by scavenging ROS and upregulating endogenous antioxidant enzymes
- Particle size critically affects skin penetration: 10-20 nm particles penetrate the stratum corneum effectively, while particles >50 nm remain primarily on the skin surface
Safety Profile
ANA Gold has a favorable safety profile for topical cosmetic use. Gold nanoparticles have been used in medical applications for decades with well-characterized biocompatibility. The nanoparticle size range used in cosmetics (10-50 nm) limits systemic absorption through intact skin. No significant irritation, sensitization, or phototoxicity has been reported in dermatological testing of gold nanoparticle-peptide conjugates.
Key safety considerations:
- Gold allergy: Rare but documented. Individuals with known gold hypersensitivity (positive gold sodium thiosulfate patch test) should avoid gold-containing cosmetics
- Nanoparticle safety: Gold nanoparticles are considered biologically inert and do not release toxic ions. Unlike silver nanoparticles, they do not accumulate in tissues at levels associated with toxicity
- Peptide component: Tripeptide-1 is well-tolerated and is the same peptide backbone used in GHK-Cu, which has extensive safety data
- No systemic effects: Topical application at cosmetic concentrations does not produce measurable systemic gold levels
Pharmacokinetic Profile
ANA Gold (Gold Tripeptide-1) — Pharmacokinetic Curve
TopicalQuick Start
- Route
- Topical
Research Protocols
topical
Safety Profile ANA Gold has a favorable safety profile for topical cosmetic use.
Quality Indicators
What to look for
- Well-established safety profile
Frequently Asked Questions
References (7)
- [8]
- [6]
- [7]
- [9]Negari et al Peptide-based cosmeceuticals: mechanisms and clinical applications Int J Mol Sci (2023)
- [10]
- [1]
- [4]Lintner K et al Cosmetic peptides Int J Cosmet Sci (2009)
Amylin (IAPP)
Amylin (Islet Amyloid Polypeptide, IAPP) is a 37-amino-acid pancreatic hormone co-secreted with insulin from beta cells. It regulates gastric emptying, promotes satiety, and suppresses glucagon. It is the parent compound for pramlintide (Symlin) and cagrilintide (in CagriSema).
Angiostatin
Angiostatin is a 38 kDa endogenous angiogenesis inhibitor derived from plasminogen kringle domains 1-4. Discovered by Judah Folkman's laboratory in 1994, it inhibits endothelial cell proliferation and migration by binding cell-surface ATP synthase and inducing apoptosis. Angiostatin demonstrated remarkable tumor dormancy in preclinical models and has been investigated in clinical trials as recombinant human angiostatin for cancer therapy, both as monotherapy and in combination with chemotherapy and radiation.